ArticleJournal of experimental & clinical cancer research : CR2026
NRGN inhibits CD8⁺ T cell effector function by downregulating MHC-I expression through the FMR1-IRF8 axis in hepatocellular carcinoma.
Dongjie Ye et al.PubMed ↗Publisher ↗
No numbers read from the abstract.